A roundup of a few recent stories from the press about Vanderbilt University Medical Center:
William Schaffner, MD, professor of Preventive Medicine, continues to be one of the most in-demand sources about COVID-19, influenza and other subjects in the news. The emergence of the omicron variant has especially given him opportunities to speak to reporters and provide information and context. Among the news organizations he has spoken with recently: NBC News, CNN, MSNBC, Salon, Daily Mail, Prevention, Bloomberg, Healthline, and PolitiFact,
Buddy Creech, MD, director of the Vanderbilt Vaccine Research Program, was interviewed for a Politico story about future plans for COVID vaccinations for toddlers and babies.
Champaign-Urbana News-Gazette editor Jeff D’Alessio interviewed Keipp Talbot, MD, associate professor of Medicine in the Division of Infectious Diseases, for a story about the omicron variant.
News-Medical scientific editor Danielle Ellis interviewed Jeffrey Rathmell, PhD, Cornelius Vanderbilt Chair in Pathology, Microbiology and Immunology and director of the Vanderbilt Center for Immunobiology, for a story about his study, “CRISPR screen identifies new anti-inflammatory drug target.”